3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
23
Peritoneal Neoplasms
15
Fallopian Tube Neoplasms
10
Colorectal Neoplasms
8
Stomach Neoplasms
6
Carcinoma, Ovarian Epithelial
5
Neoplasms
3
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Brain Neoplasms
2
Appendiceal Neoplasms
2
Adrenocortical Carcinoma
2
Adenoma, Islet Cell
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Postoperative Complications
1
Peritoneal Cavity Cancer
1
Peritoneal Cancer
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neuroblastoma
1
Interventions
Oxaliplatin
180
Capecitabine
174
Fluorouracil
154
Radiotherapy
107
Leucovorin
107
Irinotecan
93
Bevacizumab
69
Surgical Procedures, Operative
49
Cetuximab
39
Drug Therapy
38
Radiation
35
Neoadjuvant Therapy
33
Folfox protocol
29
Chemoradiotherapy
29
XELOX
22
Magnetic Resonance Spectroscopy
21
Chemotherapy, Adjuvant
21
Radiotherapy, Intensity-Modulated
19
Surveys and Questionnaires
17
Proctectomy
16
Biopsy
16
Early Intervention, Educational
14
trifluridine tipiracil drug combination
12
Panitumumab
12
Floxuridine
12
tislelizumab
11
regorafenib
11
Nivolumab
11
Laparoscopy
11
Celecoxib
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Rectal Neoplasms
×
Cytoreduction Surgical Procedures
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled